Strides Shasun
-
Strides Shasun announces Q4 FY18 and FY18 results
Strides Shasun Limited (BSE: 532531, NSE: STAR) today announced its Q4 FY18 and FY 18 results Performance Highlights – Q4…
Read More » -
Strides Shasun receives USFDA approval for Cinacalcet Hydrochloride Tablets
Strides Shasun Limited today announced that its wholly owned subsidiary Strides Pharma Global Pte. Limited has received final approval for…
Read More »